These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2052403

  • 1. Administration of beta-glucan following Leishmania major infection suppresses disease progression in mice.
    Goldman R, Jaffe CL.
    Parasite Immunol; 1991 Mar; 13(2):137-45. PubMed ID: 2052403
    [Abstract] [Full Text] [Related]

  • 2. Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.
    Mitchell GF, Handman E, Spithill TW.
    Aust J Exp Biol Med Sci; 1984 Apr; 62 ( Pt 2)():145-53. PubMed ID: 6466205
    [Abstract] [Full Text] [Related]

  • 3. Effect of glucan on Leishmania major infection in BALB/c mice.
    Al Tuwaijri AS, Mahmoud AA, Al Mofleh IA, Al Khuwaitir SA.
    J Med Microbiol; 1987 Jun; 23(4):363-5. PubMed ID: 3585970
    [Abstract] [Full Text] [Related]

  • 4. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
    Kahl LP, Scott CA, Lelchuk R, Gregoriadis G, Liew FY.
    J Immunol; 1989 Jun 15; 142(12):4441-9. PubMed ID: 2786033
    [Abstract] [Full Text] [Related]

  • 5. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA.
    J Immunol; 1989 Jul 01; 143(1):266-74. PubMed ID: 2499629
    [Abstract] [Full Text] [Related]

  • 6. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1985 Sep 15; 135(3):2095-101. PubMed ID: 4020140
    [Abstract] [Full Text] [Related]

  • 8. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
    Mitchell GF, Handman E.
    Aust J Exp Biol Med Sci; 1983 Feb 15; 61(Pt 1):11-25. PubMed ID: 6870673
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major.
    Behforouz NC, Wenger CD, Mathison BA.
    J Immunol; 1986 Apr 15; 136(8):3067-75. PubMed ID: 3958489
    [Abstract] [Full Text] [Related]

  • 10. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M, Jafari D, Abolghazi M, Farahani H, Niknam HM.
    Parasitol Res; 2018 Sep 15; 117(9):2949-2956. PubMed ID: 29978420
    [Abstract] [Full Text] [Related]

  • 11. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P, Pearce E, Natovitz P, Sher A.
    J Immunol; 1987 Jul 01; 139(1):221-7. PubMed ID: 3495599
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of humoral immune response to Leishmania tropica in an experimental model.
    Rostamian M, Akya A, Niknam HM.
    Parasitol Res; 2019 Apr 01; 118(4):1231-1237. PubMed ID: 30778754
    [Abstract] [Full Text] [Related]

  • 13. Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice.
    Rostamian M, Sohrabi S, Kavosifard H, Niknam HM.
    J Microbiol Immunol Infect; 2017 Apr 01; 50(2):160-166. PubMed ID: 26066544
    [Abstract] [Full Text] [Related]

  • 14. Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice.
    McGurn M, Boon T, Louis JA, Titus RG.
    Exp Parasitol; 1990 Jul 01; 71(1):81-9. PubMed ID: 1972362
    [Abstract] [Full Text] [Related]

  • 15. A new vaccination procedure against cutaneous leishmaniasis.
    Vouldoukis I, Frommel D, Ogunkolade BW, Monjour L.
    Ann Trop Med Parasitol; 1989 Dec 01; 83(6):645-6. PubMed ID: 2619382
    [No Abstract] [Full Text] [Related]

  • 16. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
    Müller I, Pedrazzini T, Kropf P, Louis J, Milon G.
    Int Immunol; 1991 Jun 01; 3(6):587-97. PubMed ID: 1909563
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the immune response of Balb/c mice against Leishmania major by imuvert.
    Taha SM, Tabbara KS.
    Int J Immunopharmacol; 1997 Aug 01; 19(8):443-9. PubMed ID: 9568550
    [Abstract] [Full Text] [Related]

  • 18. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 01; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 19. Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent.
    Lezama-Davila CM, Williams DM, Gallagher G, Alexander J.
    Parasite Immunol; 1992 Jan 01; 14(1):37-48. PubMed ID: 1557229
    [Abstract] [Full Text] [Related]

  • 20. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.
    Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D.
    Korean J Parasitol; 2007 Dec 01; 45(4):247-53. PubMed ID: 18165706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.